SCHEMBL18248911

SCHEMBL18248911

CN=C(N)c1ccnc2nc[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PBK Q96KB5 4/20 0.41
▸ BRD4 O60885 3/20 0.40
▸ ALDH1A1 P00352 1/20 0.36
▸ PI4KA P42356 2/20 0.36
▸ PI4K2B Q8TCG2 2/20 0.36
▸ PI4K2A Q9BTU6 2/20 0.36
▸ PI4KB Q9UBF8 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ DRD3 P35462 1/20 0.36
▸ XDH P47989 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36
▸ CYP3A4 P08684 6/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ CYP3A5 P20815 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18248944 0.85 PBK (0.42) PBKBRD4ALDH1A1PI4KAPI4K2B
SCHEMBL18248945 0.85 PBK (0.42) PBKBRD4ALDH1A1PI4KAPI4K2B
SCHEMBL18225866 0.80 PBK (0.40) PBKBRD4CYP3A4CYP1A2HIF1A
SCHEMBL2005978 0.78 PBK (0.50) PBKBRD4ALDH1A1LRRK2CYP3A4
SCHEMBL18225726 0.78 PBK (0.44) PBKBRD4ALDH1A1PI4KAPI4K2B
SCHEMBL18226537 0.75 AKT2 (0.41) PBKBRD4LMNACYP3A4CYP3A5
SCHEMBL18225136 0.74 PARP1 (0.37) —
SCHEMBL18249290 0.74 CYP3A4 (0.45) BRD4LMNALRRK2CYP3A4CYP3A5
SCHEMBL18248953 0.74 HTR3E (0.44) PBKBRD4ALDH1A1LMNACYP3A4
SCHEMBL18248929 0.73 HTR3E (0.49) BRD4ALDH1A1LMNALRRK2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294732-A1 BENZIMIDAZOLE AND IMADAZOPYRIDINE CARBOXIMIDAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE Gilead Sciences, Inc. (US) 2018-03-21 — — EP disclosed
WO-2016186967-A1 BENZIMIDAZOLE AND IMADAZOPYRIDINE CARBOXIMIDAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE GILEAD SCIENCES, INC. (US) 2016-11-24 — — WO disclosed
Send feedback